1.66 and median of (3.02). Addex Therapeutics Gross Profit is very stable at the moment as compared to the past year. Addex Therapeutics reported last year Gross Profit of 1.42 Million. As of 21st of September 2023, Revenues is likely to grow to about 2.2 M, while Consolidated Income is likely to drop (21.4 M).Addex Therapeutics Enterprise Value over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value over EBITDA is likely to grow to 0.31 this year. During the period from 2010 to 2023, Addex Therapeutics Enterprise Value over EBITDA quarterly data regression pattern had sample variance of
Addex Therapeutics Quarterly Enterprise Value over EBITDA
Check Addex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Addex main balance sheet or income statement drivers, such as Gross Profit of 2.2 M, Interest Expense of 310.2 K or Operating Expenses of 19.9 M, as well as many exotic indicators such as Asset Turnover of 0.12, Book Value per Share of 0.8 or Current Ratio of 2.45. Addex financial statements analysis is a perfect complement when working with Addex Therapeutics Valuation or Volatility modules.This module can also supplement various Addex Therapeutics Technical models . Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
Addex Enterprise Value over EBITDA Breakdown
Showing smoothed Enterprise Value over EBITDA of Addex Therapeutics with missing and latest data points interpolated. Measures the ratio between [EV] and [EBITDAUSD]. Addex Therapeutics' Enterprise Value over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Addex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
|Enterprise Value over EBITDA||10 Years Trend|
Enterprise Value over EBITDA
Addex Enterprise Value over EBITDA Regression Statistics
Addex Enterprise Value over EBITDA History
About Addex Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Addex Therapeutics income statement, its balance sheet, and the statement of cash flows. Addex Therapeutics investors use historical funamental indicators, such as Addex Therapeutics's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Addex Therapeutics investors may use each financial statement separately, they are all related. The changes in Addex Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Addex Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Addex Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Addex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Be your own money managerOur tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
State of the art Portfolio Manager to monitor and improve performance of your invested capital
|All Next||Launch Module|
Pair Trading with Addex TherapeuticsOne of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.
Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Addex Stock analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.